Zinc Therapy in Dermatology: A Review by Mrinal Gupta, Vikram K. Mahajan, Karaninder S. Mehta, Pushpinder S. Chauhan

Get full text

CAR-T CELL THERAPY FOR T-CELL MALIGNANCIES by Ugo Testa, Patrizia Chiusolo, Elvira Pelosi, Germana Castelli, Giuseppe Leone

“… Chimeric antigen receptor T-cell (CAR-T) therapy has revolutionized the treatment of B-cell lymphoid neoplasia and, in some instances, improved disease outcomes. …”
Get full text

Editorial: Antiviral monoclonal antibody therapies by Catalina Florez, Catalina Florez, Denise Haslwanter, Rohit K. Jangra, Rohit K. Jangra, Rohit K. Jangra

Get full text

Cognitive Group Therapy for Test Anxiety by Sevinc ULUSOY, Kaasim Fatih YAVUZ, Fatma Betul ESEN, Gokhan UMUT, Hasan Turan KARATEPE

Subjects: Get full text

Iron Chelation Therapy in Myelodysplastic Syndromes by Emanuela Messa, Daniela Cilloni, Giuseppe Saglio

“…In low-risk patients, transfusion dependency can be long lasting, leading to iron overload. Iron chelation therapy may be a therapeutic option for these patients, especially since the approval of oral iron chelators, which are easier to use and better accepted by the patients. …”
Get full text

Role of 5-ASA in IBD Therapy by CN Williams

Get full text

Inflammation as a Target in Cancer Therapy by Sonia Leon-Cabrera, Kathryn L. Schwertfeger, Luis I. Terrazas

Get full text

Photopsias during Systemic Bevacizumab Therapy by Heather Leisy, Meleha Ahmad, R. Theodore Smith

Get full text

The Role of Exosomes in Cancer Progression and Therapy by Shynggys Sergazy, Roza Seydahmetova, Alexandr Gulyayev, Zarina Shulgau, Mohamad Aljofan

Subjects: Get full text

Macular Hole: From Diagnosis to Therapy by Claudio Azzolini

Get full text

Arterial Emboli Complicating Cisplatin Therapy by Campbell D. Tait, Elaine M. Rankin

Get full text

Understanding and Prevention of “Therapy-” Induced Dyskinesias by Iciar Aviles-Olmos, Zinovia Kefalopoulou, Thomas Foltynie

“…However, the spectre of dyskinesia in the absence of L-dopa, the so-called “off-phase” or graft-induced dyskinesia (GID), remains a major obstacle particularly in the further development of cell therapy in PD, but it is also a concern for proponents of gene therapy approaches. …”
Get full text

Intravenous-to-Oral Conversion Therapy for Antimicrobials by John M Conly, Stephen D Shafran

Get full text

Amodiaquine and Ciprofloxacin Combination in Plasmodiasis Therapy by Peace Mayen Edwin Ubulom, Chinweizu Ejikeme Udobi, Mark Iheukwumere Madu

“…Conversely, the combination therapy of Amodiaquine and Ciprofloxacin had a significant antiplasmodial effect at all the doses administered. …”
Get full text

Stem Cells in Cancer Progression and Therapy by Hua Tan, Weijun Su, Xing-Ding Zhang

Get full text

CAR-T CELL THERAPY FOR FOLLICULAR LYMPHOMAS by Ugo Testa, Francesco D'Alò, Elvira Pelosi, Germana Castelli, Giuseppe Leone

“…Chimeric antigen receptor (CAR)-T cell therapy targeting B-cell antigens, such as CD19 or CD20, is emerging as an efficacious treatment for R/R follicular lymphoma patients, particularly for those with early relapse and refractory to alkylating agents and to anti-CD20 monoclonal antibodies, resulting in a high rate of durable responses in a high proportion of patients.   …”
Get full text

New Antibody Conjugates in Cancer Therapy by Serengulam V. Govindan, David M. Goldenberg

Get full text

The Clinical Cost of Delays in Switching Therapy by Sharon Walmsley

“…New guidelines suggest that the goal of therapy should be maximal virological suppression. …”
Get full text

The Role of Bridging Therapy in Hepatocellular Carcinoma by Roberto Galuppo, Angie McCall, Roberto Gedaly

“…We are also presenting our single-center experience of 96 patients undergoing transplantation for HCC with and without bridging therapy.…”
Get full text

Infusion therapy for chronic liver diseases by I. A. Kurkina, M. V. Mayevskaya, I. N. Tikhonov, V. N. Zozulya, V. I. Leschenko

“…To present modern options of comprehensive infusion therapy at various liver diseases, indications and contraindications for application of basic blood substitute groups, and pathogenically justified approaches for their use. …”
Get full text